Catalyst News and Research

RSS

Biochemists detect subtle new gyration that protein molecules undergo

Biochemists have detected a surprising, subtle new gyration that protein molecules undergo in the intricate, squirming dance that influences their activity in the cell.

7 Feb 2006

Breakthrough in lupus research

A major breakthrough in lupus research - one that may fundamentally change thinking on how the disease affects behavior and cognition - was reported in the January 17, 2006 Proceedings of the National Academy of Sciences (PNAS).

25 Jan 2006

AIDS drugs from sunflowers

Sunflowers can produce a substance which prevents the AIDS pathogen HIV from reproducing, at least in cell cultures. This is the result of research carried out by scientists at the University of Bonn in cooperation with the caesar research centre.

9 Jan 2006

Hydrogels to potentially make chemotherapy and tissue regeneration more convenient and safe

Scientists at the Institute of Bioengineering and Nanotechnology (IBN) have invented an injectable and biodegradable gel that can deliver drugs at targeted sites or act as a scaffold for tissue repair.

15 Dec 2005

The glow points the way: coupled enzyme test helps in the search for the right biocatalyst

The chemical industry is going biological: the use of biocatalysts, called enzymes, allows many products to be prepared very efficiently, economically, and in an environmentally safe manner.

From The University of Manchester 14 Dec 2005

Findings may help in development of new anti-inflammatory compounds

Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma, multiple sclerosis, lung and colon cancers and Alzheimer's disease.

2 Dec 2005

Protein discovery may have implications for treating E. coli 0157:H7 infection

A discovery by Queen's researchers of a previously unknown protein may open the door to more effective treatment of a deadly strain of the E. coli bacteria.

14 Nov 2005

New understanding of sphingosine kinases called SphK1 and SphK2

Virginia Commonwealth University Massey Cancer Center researchers have found that two enzymes that catalyze the same reaction and produce the same product have opposite effects on cell growth and death.

7 Nov 2005

New strategies to help developing countries address neglected diseases

For the health challenges facing developing countries, the numbers alone are staggering. Every day, 40,000 people - enough to fill a sports stadium - die from preventable infectious diseases and malnutrition. Entire generations of human potential are perishing.

25 Oct 2005

New technique could provide a long jump forward in spotting athletes' use of banned substances

A new technique could provide a long jump forward in spotting athletes' use of banned substances, according to research published today in the journal Rapid Communications in Mass Spectrometry.

13 Oct 2005

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

26 Sep 2005

Adult human neural stem cells used to successfully regenerate spinal cord tissue

Researchers at the UC Irvine Reeve-Irvine Research Center have used adult human neural stem cells to successfully regenerate damaged spinal cord tissue and improve mobility in mice.

26 Sep 2005

Virginia Tech engineer investigates enzyme link to Huntington's, Parkinson's, and Alzheimer diseases

Several neurologically based afflictions, such as Huntington's, Parkinson's, and Alzheimer diseases, have been correlated to a higher than normal presence of a specific type of enzymes, called transglutaminases (TGase) in the human body.

30 Aug 2005

Chemists synthesize new class of carbenes - potential for pharmaceutical industry

Chemists at the University of California, Riverside have synthesized a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.

22 Aug 2005

Scientists enhance the anti-cancer properties of a digitalis, a drug commonly used to treat heart disease

Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.

9 Aug 2005

Bill Clinton leads childhood obesity fight

Former President Bill Clinton, famous for among other things, his love of fast food, says he has firsthand experience of how unhealthy eating habits can do to a young body.

8 Aug 2005

Innovation that helps locate and treat life-threatening heart arrhythmias

The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.

26 Jul 2005

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

An analysis of more than 100 studies of cancer survivors shows that many survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis, but that those who are male, older, and less educated are less likely to adopt such changes. The term "cancer survivor" refers to a person who has been diagnosed with cancer.

25 Jul 2005

Chronic Obstructive Pulmonary Disease (COPD) rates in women skyrocket

The death rate for one of the most lethal diseases in North America has skyrocketed for women in the last 20 years, and a team of researchers from the University of British Columbia and the B.C. Centre of Excellence for Women's Health wants to find out why.

19 Jul 2005

Enzyme known as cathepsin G may be a target for anti-inflammatory treatments

The finding by researchers at Washington University School of Medicine in St. Louis shows that an enzyme known as cathepsin G regulates the ability of immune cells known as neutrophils to secrete chemicals that attract other immune cells and start the local inflammatory process. Over time, the excessive accumulation of immune cells can lead to tissue and cartilage damage in joints, causing pain and limiting mobility.

27 Jun 2005